CAS-Envision

Shenzhen CAS-Envision Medical Technology Co., Ltd.is a high-tech start-up enterprise held by SIAT (Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences). Relying on first-class talents introduced from overseas, it established “artificial retina” Guangdong innovation team and Shenzhen peacock team and industrialized their technical achievements.

In 2016, the team won the national champion team of biomedical industry in the China Innovation and Entrepreneurship Competition, the highest standard innovation competition in China. The preliminary R & D has received a huge subsidy of nearly 100 million yuan from government and CAS. The company present main goal is to develop high-resolution artificial retina products and derivative technologies which are international leading and domestic pioneering. The company has formed a close strategic cooperation with SIAT and it is capable of carrying out high-level R & D on a series of high-configuration platforms. It established a joint laboratory with CAS to jointly train high-end R&D talents. It has R & D conditions and innovation culture in line with international standards.

The company's vision is to become the leader and pioneer of brain-computer interface, neural regulation and other future emerging industries, it is committed to developing long-term implanted medical microsystem, providing advanced high-density neural prosthesis and core technology solutions, and applying cutting-edge technology to visual rehabilitation and assistance for the majority of the visually impaired .

SARS-CoV-2 Antigen Rapid Detection Kit（Self-Test）
SARS-CoV-2 Antigen Rapid Detection Kit（Self-Test）High resolution retinal prosthesisSARS-CoV-2 Antigen Rapid Detection kitSARS-CoV-2 Antigen Rapid Detection Kit（2.0）One-stop Solution System Provider for Personal Epidemic PreventionFully Integrated Digital PCRSARS-CoV-2 Antigen Rapid Detection Kit（Self-Test）Environmental Reusable Epidemic Prevention Kit